Personality disorders as predictors of treatment outcome in a sample of alcohol dependent veterans with comorbid axis I disorders

Similar documents
Do genetic influences on abuse and dependence overlap? Explorations using cannabis and alcohol diagnoses

Reliability of lifetime drinking history among alcoholic men

The role of family conflict as a moderator of alcoholism outcomes among offspring of alcoholics

Common and unique genetic contributions to conduct disorder and two stages of alcohol dependence development in women

Early cigarette use behaviors and alcohol

Gender differences in the prevalence and patterns of alcohol use among 9th-12th graders in a St. Louis suburban high school

Panic symptoms, cigarette smoking and drinking in adolescent female twins

Race, tobacco, and alcohol in a high risk family study

Australian children of alcoholic female twins

Alcohol use disorders and teenage sexual intercourse

Stimulant users are sensitive to the stimulant properties of alcohol as indexed by alcohol-induced heart rate increase

The relationship between adolescent/young adult BMI and subsequent non-problem and problem alcohol use

Diffusing the Stress in Financial Distress: The Intersection of Bankruptcy and Mental Health

Smoking in offspring of alcoholic twins

Characteristics of Clients Receiving Texas COSIG Services. Data through May Characteristics at Admission to COSIG Services

9/12/2012 ALCOHOL AND DRUG USE, ASSOCIATED DISORDERS AND THEIR PSYCHIATRIC COMORBIDITIES IN U.S. ADULTS OBJECTIVES

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Personality Disorder: the clinical management of borderline personality disorder

Treatment of opioid dependent individuals. Setting Up a Buprenorphine Clinic One Year Later 111 & THEIR TREATMENT DISORDERS

Early use of alcohol, tobacco, and illicit substances: Risks from parental separation and parental alcoholism

TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness

A Clinical Translation of the Research Article Titled Antisocial Behavioral Syndromes and. Additional Psychiatric Comorbidity in Posttraumatic Stress

PSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH

Comorbidity of alcoholism and antisocial personality disorder

Fabrizio Didonna, Paolo Zordan, Elena Prunetti, Denise Rigoni, Marzia Zorzi, Marco Bateni Unit for Anxiety and Mood Disorders Unit for Personality

Chapter 29. Caring for Persons With Mental Health Disorders

Minneapolis VA s Intensive Outpatient Program (IOP): Screening, Treating, and Tracking Veterans

The association of early risky behaviors and substance dependence and depression in an ethnically diverse sample

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

VA physicians usually do not detect and treat substance use disorders within the primary care setting

The Brief Addiction Monitor (BAM): A Tool to Support Measurement-based Care for People with Substance Use Disorders

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Comorbid substance use disorders and mental health disorders among New Zealand prisoners. Ian Garrett Regional Director Practice Delivery

Awareness of Borderline Personality Disorder

Genetic and environmental influences on alcohol drinking behavior

GAP e comorbidità psichiatrica. Eugenio Aguglia. Università di Catania, Dipartimento di Medicina Clinica e Sperimentale

With a lifetime prevalence of 30%, alcohol use disorders

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Vivitrol/Suboxone. Comparison Study Summary

Clinical Implications for Four Drugs of the DSM-IV Distinction Between Substance Dependence With and Without a Physiological Component

Complex Mental Illness and Concurrent Addictions

Integrating MH/SA Treatment in Primary Care Firm Clinics: The Behavioral Health Clinic

Twelve-Month Test-Retest Reliability of the Structured Clinical Interview for DSM-III-R Personality Disorders in Cocaine-Dependent Patients

Impact of Stressful Life Events on Alcohol Relapse

2007: Alcohol Use Across the Lifespan

Anxiety Disorders.

Personality Disorders and Retention in a Therapeutic Community for Substance Dependence

GIOCO D AZZARDO PATOLOGICO E COMORBIDITÀ PSICHIATRICHE

Reducing the HIV Burden: The PATH for Triples Intervention (PFT)

REVIEW ARTICLE MANAGEMENT OF PATIENTS WITH MOOD DISORDERS AND COMORBID SUDS

DIAGNOSIS OF PERSONALITY DISORDERS: SELECTED METHODS AND MODELS OF ASSESSMENT 1

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

The Addiction Severity Index in Clinical Efficacy Trials of Medications for Cocaine Dependence

Early Maladaptive Schemas And Personality. Disorder Symptoms An Examination In A Nonclinical

Dialectical Behaviour Therapy in an Outpatient Drug and Alcohol Setting

Psychiatric Comorbidities I

Alcohol and nicotine use and dependence: Common genetic and other risk factors

Advances in Clinical Research for Prescription Opioid Dependence

Comorbidity of Depression and Other Diseases

The Sinclair Method (TSM) for the Treatment of Alcoholism. Clinical Research Findings and Best Protocol for Success Updated 2014

Why Should I Care? Substance Use, Mental Health and Problem Gambling. Charles D. Maurer, PhD NAADAC 2014 Annual Conference Seattle, WA

Pharmacotherapy of Alcohol Use Disorders

SCREENING FOR PSYCHIATRIC COMORBIDITY AMONG FEMALE ALCOHOLICS: THE USE OF A QUESTIONNAIRE (SCL-90) AMONG WOMEN EARLY IN THEIR TREATMENT PROGRAMME

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

Vivitrol Vs. Suboxone

Psychiatric Symptomatology among Individuals in Alcohol Detoxification Treatment

9/16/2016. I would feel comfortable dispensing/prescribing varenicline to a patient with a mental health disorder. Learning Objectives

Can my personality be a disorder?!

Everything You Always Wanted to Know about PTSD and Substance Abuse, But Were Afraid to Ask: Now You Can!

Allen County Community Corrections. Modified Therapeutic Community. Report for Calendar Years

ORIGINAL ARTICLES. Methods and Materials

Personality Disorders. Mark Kimsey, M.D. March 8, 2014

Extended-Release Naltrexone for Opioid Relapse Prevention

Redefining personality disorders: Proposed revisions for DSM-5

Personality disorders. Personality disorder defined: Characteristic areas of impairment: The contributions of Theodore Millon Ph.D.

The Use of Collateral Reports for Patients with Bipolar and Substance Use Disorders

Patient Predictors of Response to Interpersonal Psychotherapy (IPT) for Depression

Substance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %

History of Maltreatment and Psychiatric Impairment in Children in Outpatient Psychiatric Treatment

A pilot randomised controlled trial of varenicline versus oral naltrexone for the treatment of alcohol dependence. Background 1

Five Factor Model Prototype Matching Scores: Convergence Within Alternative Methods

DBT Modification/ Intervention

Depression often comorbid with alcohol dependence 1.6x higher rate of alcohol dependence in depressed subjects Depressed subjects with alcohol

COMORBIDITY OF ALCOHOL DEPENDENCE AND PERSONALITY DISORDERS: A COMPARATIVE STUDY

ABACUS Counselling, Training and Supervision Ltd

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION

Therapeutic communities for drug addicts: Prediction of long-term outcomes

OVERVIEW OVERVIEW MINDFULNESS APPROACHES IN ADDICTION TREATMENT AND! LONG-TERM RECOVERY MANAGEMENT THERISSA LIBBY! METROPOLITAN STATE UNIVERSITY

Can my personality be a disorder?!

Childhood ADHD is a risk factor for some Psychiatric Disorders and co-morbidities

The Chemical Independent

Management of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013

9/22/2015. Timothy W. Lineberry, MD Chief Medical Officer Greater Green Bay Aurora Health Care

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

Limiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt?

OPIOID ANTAGONISTS IN THE TREATMENT OF ALCOHOL DEPENDENCE: CLINICAL EFFICACY AND PREVENTION OF RELAPSE

Relationship Between Clinician Assessment and Self-Assessment of Personality Disorders Using the SWAP-200 and PAI

TITLE: Group Therapy for Adults with Axis II Disorders: A Review of Clinical Effectiveness

Returning Veterans With Addictions

Managing Personality Disorders in Primary Care

Transcription:

Washington University School of Medicine Digital Commons@Becker Posters 2005: Alcoholism and Comorbidity 2005 Personality disorders as predictors of treatment outcome in a sample of alcohol dependent veterans with comorbid axis I disorders Elizabeth Ralevski Bruce Rounsaville James Poling Charla Nich Carolyn Levinson See next page for additional authors Follow this and additional works at: http://digitalcommons.wustl.edu/guzeposter2005 Part of the Medicine and Health Sciences Commons Recommended Citation Ralevski, Elizabeth; Rounsaville, Bruce; Poling, James; Nich, Charla; Levinson, Carolyn; and Petrakis, Ismene, "Personality disorders as predictors of treatment outcome in a sample of alcohol dependent veterans with comorbid axis I disorders" (2005). Posters. Paper 12 Samuel B. Guze Symposium on Alcoholism. http://digitalcommons.wustl.edu/guzeposter2005/12 This Poster is brought to you for free and open access by the 2005: Alcoholism and Comorbidity at Digital Commons@Becker. It has been accepted for inclusion in Posters by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.

Authors Elizabeth Ralevski, Bruce Rounsaville, James Poling, Charla Nich, Carolyn Levinson, and Ismene Petrakis This poster is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/guzeposter2005/12

PERSONALITY DISORDERS AS PREDICTORS OF TREATMENT OUTCOME IN A SAMPLE OF ALCOHOL DEPENDENT VETERANS WITH COMORBID AXIS I DISORDERS Elizabeth Ralevski PhD, Bruce Rounsaville MD, James Poling PhD, Charla Nich, Carolyn Levinson,Ismene Petrakis MD This study was supported by Veterans Affairs VISN I Mental Illness Research Education Clinical Center (MIRECC), VA Merit Review Grant, Stanley Research Foundation Grant

Background Antisocial personality disorder (ASPD) and Borderline personality disorder (BPD) are most frequently diagnosed Axis II disorders among substance abusers Rates vary from 25% to 75% Patients with ASPD and BPD have worse treatment outcomes Several problems with research in this area Studies comparing patients with ASPD or BPD are sparse The mediating role of ASPD and BPD is poorly understood What is the frequency of BPD and ASPD in dually diagnosed (substance abuse and Axis I disorders)?

Hypothesis Specific Aim 1: To examine the rates of Axis II disorders in dually diagnosed veterans who participated in a clinical trial What are the rates of ASPD and BPD among dually diagnosed patients? What is the distribution of Axis I disorders in patients with ASPD versus BPD? Specific Aim 2: To investigate the effect of personality on treatment variables and outcome Are patients with ASPD or BPD less likely to respond to treatment than patients with no diagnosis of ASPD or BPD? Will patients with ASPD or BPD exhibit more significant alcohol and psychiatric pathology - measured by various scales than patients with no diagnosis of ASPD or BPD?

225 veterans Inclusion Criteria Age 18-60 SUBJECTS Axis I Psychiatric Disorder Alcohol Dependence and recent drinking (past 30 days) Exclusion Criteria Current opiate dependence or treatment with opioid medication Significant underlying medical issues Psychiatric instability

Study Design 12 week outpatient study Patients were assigned to 1 of 4 treatment groups (naltexone, placebo, disulfiram & placebo, and disulfiram & naltrexone) Axis I and Axis II disorders were assessed at baseline Outcome measures were administered at baseline and weekly

Measures Structured Clinical Interview for DSM-IV Axis I (SCID I) Structured Clinical Interview for DSM-IV Axis II (SCID II) ASPD and BPD diagnoses only Primary Treatment Outcomes Alcohol use & craving Time Line Follow Back (TLFB), Obsessive Compulsive Drinking Scale (OCDS) Secondary Treatment Outcomes Psychiatric symptoms Brief Symptom Inventory (BSI)

Demographic Characteristics ASPD+BPD (n=42) ASPD (n=54) BPD (n=26) Neither PD* (n=103) Age (years) 43.5 (8.4) 44.3 (5.9) 49.3 (9.3) 49.1 (8.5) Gender (male) 40 (95%) 54 (100%) 26 (100%) 99 (96%) Caucasian 29 (69%) 41(76%) 19 (73%) 77 (75%) Not Married 11 (26%) 19 (35%) 7 (27%) 19 (18%) Employed full-time 18 (43%) 32 (59%) 15 (58%) 52 (50%) Skilled work 10 (24%) 28 (52%) 5 (19%) 24 (23%) Education (years) 12.7 (1.6) 12.6 (1.5) 13.1 (2.1) 13.1 (2.1) * Personality Disorder (PD)

Rates of Axis I disorders in patients with and without personality disorders ASPD+BPD (n=42) ASPD (n=54) BPD (n=26) Neither PD (n=103) Axis I diagnoses Major Depression* 27 (64%) 33 (61%) 16 (62%) 52 (50%) PTSD 15 (36%) 23 (50%) 13 (50%) 35 (34%) Cocaine dependence* Opioid dependence Lifetime* 9 (21%) 19 (35%) 6 (23%) 8 (8%) 12 (29%) 7 (13%) 5 (19%) 7 (7%) *Significantly different, p<0.05

Alcohol outcome measures for patients with and without personality disorders ASPD+BPD (n=42) ASPD (n=54) BPD (n=26) Neither PD (n=103) Measures Total heavy drinking days Mean drinking days per week % days with any drinks Mean # drinks per drinking day Consecutive weeks of abstinence 2.1 (6.1) 3.4 (7.7) 4.0 (10.5) 3.9 (9.8).21 (.57).33 (.77).56 (1.1).41 (.91) 3% 5% 8% 5% 13.4 (10.3) 19.7 (17.7) 19.0 (13.0) 13.8 (13.4) 9.9 (3.5) 9.1 (3.9) 6.7 (5.1)* 9.4 (3.7) * Significantly different, p=0.002

BSI: Hostility scores for patients with and without personality disorders 1.2 1 0.8 0.6 0.4 ASPD+BPD ASPD BPD Neither PD 0.2 0 0 1 2 3 4 5 6 7 8 9 10 11 12 Significant time x diagnosis interaction p=.0001

BSI: Paranoid ideation scores for patients with and without personality disorders 1.6 1.4 1.2 1 0.8 0.6 ASPD+BPD ASPD BPD Neither PD 0.4 0.2 0 0 1 2 3 4 5 6 7 8 9 10 11 12 Significant time x diagnosis interaction p=0.0001

Obsessive compulsive scores for patients with and without personality disorders 1.6 1.4 1.2 1 0.8 0.6 ASPD+BPD ASPD BPD Neither PD 0.4 0.2 0 0 1 2 3 4 5 6 7 8 9 10 11 12 Significant time x diagnosis interaction p=0.003

Summary Rates of ASPD are higher than rates of BPD among dually diagnosed patients Rates of major depression, lifetime opiate dependence and current cocaine dependence are higher among patients with these Personality Disorder (PD) than patients without BPD patients had fewer weeks of abstinence compared to the other groups Patients with diagnoses of both ASPD and BPD tend to be more hostile, paranoid and have more obsessive thought than patients with neither PD diagnosis or a single PD diagnosis

Conclusions Rates of ASPD and BPD in a dually diagnosed patients are compatible with rates in other studies with alcohol dependent patients Patients with ASPD and BPD are at a higher risk for abusing other substances Diagnosis of BPD may have implication for alcohol relapse Patients with more than one PD exhibit more significant pathology than patients with ASPD alone, BPD alone or neither PD diagnosis

This study was supported by